TherapeuticsMD Inc (TXMD)
1.92
+0.04
(+2.13%)
USD |
NASDAQ |
Apr 24, 16:00
1.91
-0.01
(-0.52%)
After-Hours: 20:00
TherapeuticsMD Cash from Financing (TTM): 3.151M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.151M |
| September 30, 2023 | -110.80M |
| June 30, 2023 | -109.06M |
| March 31, 2023 | -230.21M |
| December 31, 2022 | -235.21M |
| September 30, 2022 | -121.91M |
| June 30, 2022 | -91.82M |
| March 31, 2022 | 28.60M |
| December 31, 2021 | 129.55M |
| September 30, 2021 | 159.90M |
| June 30, 2021 | 128.19M |
| March 31, 2021 | 127.85M |
| December 31, 2020 | 80.72M |
| September 30, 2020 | 126.05M |
| June 30, 2020 | 125.96M |
| March 31, 2020 | 237.55M |
| December 31, 2019 | 188.83M |
| September 30, 2019 | 112.23M |
| June 30, 2019 | 202.23M |
| March 31, 2019 | 162.84M |
| December 31, 2018 | 162.79M |
| September 30, 2018 | 162.36M |
| June 30, 2018 | 140.92M |
| March 31, 2018 | 69.98M |
| December 31, 2017 | 72.58M |
| Date | Value |
|---|---|
| September 30, 2017 | 72.59M |
| June 30, 2017 | 4.022M |
| March 31, 2017 | 2.918M |
| December 31, 2016 | 137.23M |
| September 30, 2016 | 137.86M |
| June 30, 2016 | 170.21M |
| March 31, 2016 | 170.45M |
| December 31, 2015 | 92.97M |
| September 30, 2015 | 92.36M |
| June 30, 2015 | 102.90M |
| March 31, 2015 | 102.74M |
| December 31, 2014 | 43.30M |
| September 30, 2014 | 42.96M |
| June 30, 2014 | 30.54M |
| March 31, 2014 | 33.19M |
| December 31, 2013 | 73.99M |
| September 30, 2013 | 79.82M |
| June 30, 2013 | 51.30M |
| March 31, 2013 | 52.71M |
| December 31, 2012 | 14.44M |
| September 30, 2012 | 10.77M |
| June 30, 2012 | 10.17M |
| March 31, 2012 | 6.906M |
| December 31, 2011 | 4.708M |
| September 30, 2011 | 2.852M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-235.21M
Minimum
Dec 2022
237.55M
Maximum
Mar 2020
39.57M
Average
112.23M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.91M |
| Palatin Technologies Inc | 5.553M |
| iBio Inc | 10.68M |
| Theriva Biologics Inc | 0.625M |
| Oragenics Inc | 0.2839M |